July 1, 2025
Avicanna Announces Results of Annual General Meeting
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a…
Pharmaceuticals, Biotechnology and Life Sciences
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a…
SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…
Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and business growth. Attendees engage in…
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today that,…
Bexotegrast development in IPF discontinued Clinical oncology program and early-stage programs continue Recent workforce and operational changes align with next…
Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and EchocardiogramsAPOLLO BEACH,…
Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and…
FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) — Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging…
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to…
Vancouver, Canada, June 27, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…